Intervention

ipilimumab

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 14 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials14
Recruiting0
Common conditions25
Lead sponsors shown10
Advertisement

Clinical trials

14 shown
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and ChemotherapyNCT04151563 · 2021-04-15
WITHDRAWN
A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor TypesNCT04311710 · 2020-06-25
TERMINATED
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant MesotheliomaNCT04300244 · 2020-05-04
ACTIVE_NOT_RECRUITING
A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by SurgeryNCT04026412 · 2019-10-08
COMPLETED
A Study of a Personalized Cancer Vaccine Targeting Shared NeoantigensNCT03953235 · 2019-07-18
COMPLETED
A Study of a Personalized Neoantigen Cancer VaccineNCT03639714 · 2019-02-13
COMPLETED
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)NCT03663166 · 2018-11-20
TERMINATED
PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or LymphomasNCT03013491 · 2017-01-19
TERMINATED
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate CancerNCT02423928 · 2015-05-01
COMPLETED
Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic MelanomaNCT02107755 · 2014-09-05
COMPLETED
Sipuleucel-T and Ipilimumab for Advanced Prostate CancerNCT01832870 · 2013-04-01
COMPLETED
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerNCT01498978 · 2012-02-06
COMPLETED
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerNCT00060372 · 2003-04-01
COMPLETED
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerNCT00039091 · 2002-03-01
TERMINATED

Common conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities2Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)2Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)2Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)2Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)2Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative2Colorectal Cancer2Previously Treated Myelodysplastic Syndromes2Prostate Cancer2Recurrent Adult Acute Myeloid Leukemia2Recurrent Melanoma2Recurrent Ovarian Epithelial Cancer2Solid Tumor2Stage IV Melanoma2Adenocarcinoma of the Prostate1Cancer1Cancer of Lung1Cancer, Lung1Carcinoma, Non-small Cell Lung Cancer1Carcinoma, Non-Small-Cell Lung1Castrate Resistant Prostate Cancer1Childhood Myelodysplastic Syndromes1Chronic Myelogenous Leukemia, BCR-ABL1 Positive1Disseminated Neuroblastoma1Gastroesophageal Adenocarcinoma1

Trial status mix

COMPLETED8
TERMINATED4
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

PHASE110
PHASE28
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.